会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Apparatus for extracorporeal blood treatment
    • 体外血液治疗仪器
    • US09220827B2
    • 2015-12-29
    • US13816968
    • 2011-08-17
    • Joern MeibaumStefan MollAlex Castellarnau
    • Joern MeibaumStefan MollAlex Castellarnau
    • A61M37/00A61M1/14A61M1/16G01N21/33
    • A61M1/14A61M1/16A61M1/1609A61M1/1613A61M1/361A61M1/3612A61M2202/0498A61M2205/3306A61M2205/3313A61M2205/52G01N21/33
    • The invention describes an apparatus for extracorporeal blood treatment with a dialyzer which is separated by a semipermeable membrane in to a first and second chamber (29, 30), wherein the first chamber (29) is arrange in a dialysate pathway and the second chamber (30) is connectable to the blood circulation of a patient by means of a blood supply conduit (32) and a blood return conduit (31), an inlet (20) for fresh dialysate, an outlet (30) for spent dialysate, a measuring device (37) arranged in the outlet (36), wherein said measuring device (37) has at least one radiation source consisting of several light sources (1) for electromagnetic radiation. The invention is characterized in that the measuring device (37) is designed to generate substantially monochromatic electromagnetic radiation of different wavelengths, and to lead only one of these wavelength (at the same time) though the outlet (36) for spent dialysate, wherein at least one detector system (5) is provided for detection of the intensity or the absorption of the substantially monochromatic electromagnetic radiation passing through the outlet (36) for spent dialysate.
    • 本发明描述了一种用透析器进行体外血液处理的装置,其由半透膜分隔到第一和第二腔室(29,30)中,其中第一腔室(29)布置在透析液通路中,第二腔室 30)可通过血液供应管道(32)和血液回流管道(31),用于新鲜透析液的入口(20),用于透析液的出口(30),血液透析液 设置在所述出口(36)中的装置(37),其中所述测量装置(37)具有由用于电磁辐射的多个光源(1)组成的至少一个辐射源。 本发明的特征在于,测量装置(37)被设计成产生不同波长的基本上单色的电磁辐射,并且仅通过用于废透析液的出口(36)仅引导这些波长(同时)中的一个波长(其中在 提供了至少一个检测器系统(5),用于检测通过用于透析液的出口(36)的基本上单色的电磁辐射的强度或吸收。
    • 3. 发明申请
    • APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT
    • 用于提取血液治疗的装置
    • US20130237896A1
    • 2013-09-12
    • US13816968
    • 2011-08-17
    • Joern MeibaumStefan MollAlex Castellarnau
    • Joern MeibaumStefan MollAlex Castellarnau
    • A61M1/14
    • A61M1/14A61M1/16A61M1/1609A61M1/1613A61M1/361A61M1/3612A61M2202/0498A61M2205/3306A61M2205/3313A61M2205/52G01N21/33
    • The invention describes an apparatus for extracorporeal blood treatment with a dialyzer which is separated by a semipermeable membrane in to a first and second chamber (29, 30), wherein the first chamber (29) is arrange in a dialysate pathway and the second chamber (30) is connectable to the blood circulation of a patient by means of a blood supply conduit (32) and a blood return conduit (31), an inlet (20) for fresh dialysate, an outlet (30) for spent dialysate, a measuring device (37) arranged in the outlet (36), wherein said measuring device (37) has at least one radiation source consisting of several light sources (1) for electromagnetic radiation. The invention is characterized in that the measuring device (37) is designed to generate substantially monochromatic electromagnetic radiation of different wavelengths, and to lead only one of these wavelength (at the same time) though the outlet (36) for spent dialysate, wherein at least one detector system (5) is provided for detection of the intensity or the absorption of the substantially monochromatic electromagnetic radiation passing through the outlet (36) for spent dialysate.
    • 本发明描述了一种用透析器进行体外血液处理的装置,其由半透膜分隔到第一和第二腔室(29,30)中,其中第一腔室(29)布置在透析液通路中,第二腔室 30)可通过血液供应管道(32)和血液回流管道(31),用于新鲜透析液的入口(20),用于透析液的出口(30),血液透析液 设置在所述出口(36)中的装置(37),其中所述测量装置(37)具有由用于电磁辐射的多个光源(1)组成的至少一个辐射源。 本发明的特征在于,测量装置(37)被设计成产生不同波长的基本上单色的电磁辐射,并且仅通过用于废透析液的出口(36)仅引导这些波长(同时)中的一个波长(其中在 提供了至少一个检测器系统(5),用于检测通过用于透析液的出口(36)的基本上单色的电磁辐射的强度或吸收。
    • 4. 发明申请
    • DEVICE FOR EXTRACORPOREAL BLOOD TREATMENT
    • 用于提取血液治疗的装置
    • US20120217189A1
    • 2012-08-30
    • US13394021
    • 2010-09-06
    • Jörn AhrensStefan MollAlex Castellarnau
    • Jörn AhrensStefan MollAlex Castellarnau
    • A61M1/16
    • A61M1/16A61M1/1607A61M1/1609A61M2205/3313A61M2205/3334A61M2205/50A61M2205/52
    • The invention is related to an apparatus for extracorporeal treatment of blood with a dialyzer which is separated by a semipermeable membrane into a first and a second chamber, wherein the first chamber is disposed in a dialysis fluid pathway and the second chamber is connectable to the blood circulation of a patient by means of a blood inflow conduit and a blood outflow conduit, a feed for fresh dialysis fluid, a discharge for spent dialysis fluid, a means for estimation of a flow QBlood in the blood inflow conduit respectively the blood outflow conduit, a means for determining a flow QDialysate in the dialysis fluid pathway, and a measuring device disposed in the discharge for estimation of the absorption ADialysate of the spent dialysis fluid flowing through the discharge, wherein the measuring device has at least one radiation source and a detector system for detection of the intensity of the electromagnetic radiation. Therein provided are a memory, wherein a formula A Blood = ( A Dialysate · Q Dialysate Q Blood ) is stored for the absorption ABlood, and an arithmetic unit for estimation of the absorption ABlood in the blood inflow conduit respectively the blood outflow conduit using the absorption ADialysate, the flow QDialysate, and the flow QBlood.
    • 本发明涉及一种用透析器体外处理血液的装置,该透析器由半透膜分隔成第一和第二腔室,其中第一腔室设置在透析液通路中,第二腔室可连接血液 通过血液流入管道和血液流出管道,新鲜透析液体的进料,废透析液的排出物,用于分别估计血液流出管道中的血流QBlood的装置, 用于确定透析流体通路中的流动QDialysate的装置,以及设置在所述放电中用于估计流过所述放电的废透析液的吸收剂量的测量装置,其中所述测量装置具有至少一个辐射源和检测器 用于检测电磁辐射强度的系统。 其中提供了一种存储器,其中存储用于吸收ABlood的公式A Blood =(A透析液·Q透析液Q血液)和用于估计血液流入导管中的吸收ABlood的运算单元, 吸收ADDIysate,流量QDialysate和流量QBlood。
    • 5. 发明申请
    • KIDNEY SUBSTITUTION TREATMENT MACHINE
    • KIDNEY替代治疗机
    • US20120228226A1
    • 2012-09-13
    • US13394024
    • 2010-09-06
    • Alex CastellarnauJörn AhrensStefan Moll
    • Alex CastellarnauJörn AhrensStefan Moll
    • A61M1/16B01D61/34
    • A61M1/16A61M1/1605A61M1/3406A61M2202/0498A61M2205/15A61M2205/3313A61M2205/502A61M2205/52A61M2230/65
    • The invention relates to a method for normalizing, storing and/or displaying curves describing the adequacy of a kidney substitution treatment wherein the treatment is provided by a machine which has an extracorporeal blood system (31, 32) pumping the patient's blood at a preset flow rate through the blood chamber (30) of a dialyzer which is divided by a semi-permeable membrane into the blood chamber (30) and a dialyzing fluid chamber (29), and wherein the dialyzing fluid flows at a preset flow rate through the dialyzing fluid system (20, 36) of the machine and collects the waste products from the patient, and wherein a device (37) capable of continuously measuring any treatment related waste product is provided to deliver together with the data provided by the treatment machine an adequacy parameter, wherein curves describing the adequacy of the treatment are normalized to make them comparable, and/or stored in an adequate media and/or displayed on the user interface of the machine and wherein means are available to calculate parameters quantifying the adequacy differences between treatments.
    • 本发明涉及一种用于归一化,存储和/或显示描述肾脏替代治疗的适当性的曲线的方法,其中所述治疗由具有体外血液系统(31,32)的机器提供,所述体外泵送患者的血液以预设的流量 通过透析器的血液室(30)通过半透膜分成血液室(30)和透析液室(29),并且其中透析液以预设的流速通过透析 流体系统(20,36),并且收集来自患者的废物,并且其中可以连续测量任何处理相关的废物的装置(37)与处理机提供的数据一起提供足够的 参数,其中描述治疗的适当性的曲线被归一化以使其相当,和/或存储在适当的介质中和/或显示在机器的用户界面上 d其中手段可用于计算量化治疗之间充分性差异的参数。
    • 7. 发明申请
    • METHOD AND DEVICE TO EARLY PREDICT THE Kt/V PARAMETER IN KIDNEY SUBSTITUTION TREATMENTS
    • 早期预测KD / V参数在KIDNEY替代治疗中的方法和装置
    • US20110163034A1
    • 2011-07-07
    • US13063533
    • 2009-09-15
    • Alex Castellarnau
    • Alex Castellarnau
    • A61M1/16
    • A61M1/16A61M1/1609A61M1/1613A61M2202/0498A61M2205/15A61M2205/3317A61M2205/3324A61M2205/3344A61M2205/50A61M2230/65G06F19/00
    • A method for determining or predicting the adequacy parameters that will be achieved at the end of a kidney substitution treatment during said kidney substitution treatment wherein the kidney substitution treatment is provided by a machine, which has an extracorporeal blood system pumping the patient blood through the blood chamber of a dialyzer, wherein the dialyzing fluid collects the waste products from the patient after flowing through the dialyzing fluid chamber of the dialyzer and wherein a device able to measure a adequacy parameter is coupled with the kidney substitution treatment machine and wherein the slope of a preferable linear guideline for the adequacy parameter is compared to the slope of the delivered adequacy parameter and if the slope of both are equal a linearization is performed to determine or predict the adequacy parameter at the end of the kidney substitution treatment.
    • 一种用于确定或预测在所述肾脏替代治疗期间在肾脏替代治疗结束时将实现的充分性参数的方法,其中肾脏替代治疗由机器提供,该机器具有将患者血液泵送通过血液的体外血液系统 透析器的腔室,其中所述透析流体在流过透析器的透析流体室之后从患者收集废物,并且其中能够测量适当参数的装置与肾脏替代治疗机器相结合,并且其中 将适当性参数的优选线性准则与所提供的充足参数的斜率进行比较,并且如果两者的斜率相等,则执行线性化以确定或预测肾替代治疗结束时的充分性参数。
    • 8. 发明授权
    • Method and device to early predict the Kt/V parameter in kidney substitution treatments
    • 在肾脏替代治疗中早期预测Kt / V参数的方法和装置
    • US08568595B2
    • 2013-10-29
    • US13063533
    • 2009-09-15
    • Alex Castellarnau
    • Alex Castellarnau
    • B01D61/32B01D61/28A61M1/16
    • A61M1/16A61M1/1609A61M1/1613A61M2202/0498A61M2205/15A61M2205/3317A61M2205/3324A61M2205/3344A61M2205/50A61M2230/65G06F19/00
    • A method for determining or predicting the adequacy parameters that will be achieved at the end of a kidney substitution treatment during said kidney substitution treatment wherein the kidney substitution treatment is provided by a machine, which has an extracorporeal blood system pumping the patient blood through the blood chamber of a dialyzer, wherein the dialyzing fluid collects the waste products from the patient after flowing through the dialyzing fluid chamber of the dialyzer and wherein a device able to measure a adequacy parameter is coupled with the kidney substitution treatment machine and wherein the slope of a preferable linear guideline for the adequacy parameter is compared to the slope of the delivered adequacy parameter and if the slope of both are equal a linearization is performed to determine or predict the adequacy parameter at the end of the kidney substitution treatment.
    • 一种用于确定或预测在所述肾脏替代治疗期间在肾脏替代治疗结束时将实现的充分性参数的方法,其中肾脏替代治疗由机器提供,该机器具有将患者血液泵送通过血液的体外血液系统 透析器的腔室,其中所述透析流体在流过透析器的透析流体室之后从患者收集废物,并且其中能够测量适当参数的装置与肾脏替代治疗机器相结合,并且其中 将适当性参数的优选线性准则与所提供的充足参数的斜率进行比较,并且如果两者的斜率相等,则执行线性化以确定或预测肾替代治疗结束时的充分性参数。